Abstract:OBJECTIVE:To summarize the progress of surgical treatment of hepatocellular carcinoma (HCC) and related basic research at the Liver Cancer Institute of Shanghai Medical University in the recent years, with special reference to recurrence and metastasis.METHODS:Published and unpublished update clinical and experimental data in the above-mentioned areas are summarized.RESULTS:Surgical resection has played an important role in improving prognosis of HCC, the 5-year survival were 63.4% for small HCC resection (n = 806), 39.6% for large HCC resection (n = 1061), 64.7% for cytoreduction (using hepatic artery cannulation and ligation) and sequential resection of initially unresectable HCC (n = 93), 56.0% for cytoreduction using transcatheter arterial chemoembolization (TACE) and followed by resection (n = 65), and 22.4% for hepatic resection with removal of tumor thrombi in portal vein (n = 103). Unfortunately, the 5-year recurrent rate after curative resection of HCC was up to 61.5%, which was mainly a result of intrahepatic "metastasis" and multicentric origin of HCC. Clinically, re-resection of subclinical recurrence yielded 56% of 5-year survival (n = 202); prevention of recurrence by transcatheter arterial chemoembolization (TACE) + Interferon, or LAK/IL-2 therapy have decreased 3-year recurrent rate from 33% to 11%-18%. In experimental aspect, metastatic human HCC model in nude mice (LCI-D20) and HCC cell line with metastatic potential (MHCC97) have been established; studies on HCC invasiveness in the molecular level revealed similar results that reported in other solid cancers, and small HCC showed slightly better biological characteristics as compared with large HCC; microvessel density (MVD) that reflecting angiogenesis adversely correlated with 5-year survival of small HCC; experimental interventions using antisense H-ras, bispecific antibody, BB94, as well as anti-angiogenic agents (TNP470, suramin, CAI, heparin, antisense VEGF, etc.) have been demonstrated to inhibit tumor growth and lung metastasis in nude mice model.CONCLUSIONS:Recurrence and metastasis are the major obstacle to further improve prognosis of HCC, studies should be conducted both in clinical and experimental aspects, "HCC invasiveness" will be the major target to be studied, particularly in the molecular level, and anti-angiogenesis will be one of the important approach.

Progress of Hepatic-Biliary-pancreatic Surgery in the 118th Annual Congress of Japan Surgical Society

Advances in hepatopancreatobiliary surgery of the 13th World Congress of the International Hepato-Pancreato-Biliary Association

Advances in the 8th Japan-China Hepato-Pancreato-Biliary Symposium

[Current Status and Prospect of Surgical Treatment of Liver Cancer].

Ott_a_203342 8355..8365

Surgical Techniques in the Radical Resection of Hilar Cholangiocarcinoma

Progress of Pancreatic Tumor Researches in the Pancreas 2018 of Johns Hopkins Hospital

Summary and comments of the 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association

Recent Advances in Surgical Management Strategies for Hepatocellular Carcinoma

[The Progress of Chinese Surgery in 2017].

Progress in Surgical Procedures of Hepatocellular Carcinoma

Expert Consensus on Perioperative Management of Liver Transplantation in Adults with Acute-on-chronic Liver Failure

The development and prospects of liver surgery

Proceedings of the 28th Annual Congress of the International Liver Transplantation Society

Evolution and achievements of laparoscopic hepatocellular carcinoma in China over the past 20 years

Surgical Treatment of Hepatocellular Carcinoma and Related Basic Research with Special Reference to Recurrence and Metastasis

Clinicopathological features,diagnosis and treatment of hepatolithiasis complicated with cholangiocarcinoma

Progress in hepatectomy for hepatocellular carcinoma and peri-operation management

Classification and evolution of the surgical approach of laparoscopic hepatectomy

[Surgical Treatment for Pancreatic Cancer with Liver Metastasis:Exploration and Innovation].

Research on Biliary Diseases: Progresses and Challenges